During the past decade, Northwest Ohio Cardiology Consultants conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 7 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 1 clinical trials were completed. i.e. 20% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Northwest Ohio Cardiology Consultants" #1 sponsor was "Biotronik, Inc." with 4 trials, followed by "Pfizer" with 3 trials sponsored, "Abbott Medical Devices" with 2 trials sponsored, "Acutus Medical" with 2 trials sponsored and "Boston Scientific Corporation" with 2 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Northwest Ohio Cardiology Consultants" #1 collaborator was "Bristol-Myers Squibb" with 2 trials as a collaborator, "Abbott" with 1 trials as a collaborator, "Boston Scientific Corporation" with 1 trials as a collaborator, "CTI Clinical Trial and Consulting Services" with 1 trials as a collaborator and "Cordis Corporation" with 1 trials as a collaborator. Other collaborators include 3 different institutions and companies that were collaborators in the rest 13 trials.

According to Clinical.Site data, the most researched conditions in "Northwest Ohio Cardiology Consultants" are "Heart Failure" (5 trials), "Atrial Fibrillation" (3 trials), "Bradycardia" (2 trials), "Cardiovascular Disease" (2 trials) and "Congestive Heart Failure" (2 trials). Many other conditions were trialed in "Northwest Ohio Cardiology Consultants" in a lesser frequency.

Most popular intervention types in "Northwest Ohio Cardiology Consultants" are "Device" (11 trials) and "Drug" (6 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "bococizumab (PF-04950615)" (2 trials), "(BMS/DES)" (1 trials), "AcQBlate® Force Sensing Ablation System" (1 trials) and "AcQMap System" (1 trials). Other intervention names were less common.

The vast majority of trials in "Northwest Ohio Cardiology Consultants" are 20 trials for "All" genders.

Currently, there are NaN active trials in "Northwest Ohio Cardiology Consultants". undefined are not yet recruiting, 1 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Northwest Ohio Cardiology Consultants, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Northwest Ohio Cardiology Consultants, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 5 trials that are defined as “Not Applicable".